A method for separating full adeno-associated virus (AAV) capsids from empty AAV capsids in a buffered mixture comprising full AAV capsids and empty AAV capsids, comprising the steps of contacting the...
A process for the purification of influenza virus or derivative thereof requires providing a source of influenza virus or derivative thereof, optionally subjecting the source to a pre-purification ste...
A process for producing a virus-inactivated, factor VIII-containing fraction by chromatographic methods in which, starting with cryoprecipitate or blood plasma, possibly followed by a treatment with a...
A process for preparing agents containing virus-inactivated vitamin K-dependent plasma components as well as protein C, protein S, factors II, VII, IX and/or X as well as combinations thereof, such as...
A porous self-supporting structure comprising at least two porous components A and B and the porous component B embraces the porous component A, wherein surfaces of pores of the at least two porous co...
Centrifuge rotor comprising a rotor assembly adapted for centrifugal rotation around a rotation centre axis, with a plurality of centrifuge tube beds, each with a longitudinal axis, wherein each centr...
A method for removal of host cell DNA from a sample containing a species of desired protein, virus, or extracellular vesicle comprising the steps of loading a substrate bearing an anionic metal affini...
A method for reducing a contaminating DNA content of a preparation containing AAV capsids and contaminating DNA, comprising the steps of performing an extraction of DNA with a solid phase bearing posi...
A method for manufacturing a fraction comprising the proteins lactoferrin and/or lactoperoxidase from a source containing at least one of these proteins wherein the source is selected from the group c...
The present invention refers to a process for purifying virus particles from cell culture, comprising the steps of subjecting the cell culture to centrifugation to get a supernatant fraction of virus ...
A process for purifying ciprofloxacin is described wherein a solution of ciprofloxacin is contacted with a solid phase for chromatographic purification.
A process for isolating and purifying a polynucleotide on a manufacturing scale which uses a chromatographic separation process comprising a combination of two different chromatographic steps selected...
A process of manufacturing of a chromatography material comprising the steps of reacting a polymerisable at least bifunctional monomer A with a ligand also having a functional group which binds covale...
A process for the conversion of substrates both for analytical and preparative purposes in a flow-through and cross-flow reactor having compact porous discs and/or compact porous tubes as carrier for ...